<SEC-DOCUMENT>0001628280-22-031796.txt : 20221213
<SEC-HEADER>0001628280-22-031796.hdr.sgml : 20221213
<ACCEPTANCE-DATETIME>20221213160137
ACCESSION NUMBER:		0001628280-22-031796
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221213
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221213
DATE AS OF CHANGE:		20221213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		221459692

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>csbr-20221213.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:e4f48ed9-bbba-4e3a-9c1a-65b15a67e884,g:7ce3ad52-b33f-47e4-9b03-96c1a17d6b6c,d:59f578f34b82470eac9b03ea5129328d--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>csbr-20221213</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF80L2ZyYWc6YjNmN2NlYjhmY2M0NGRlZTg3YWQwNzBiODYwYWE0ZTcvdGFibGU6NTYwYWRlMDkxMDFjNDI3YTg2MWNlZmQ1MmEyMWIxNmMvdGFibGVyYW5nZTo1NjBhZGUwOTEwMWM0MjdhODYxY2VmZDUyYTIxYjE2Y18wLTEtMS0xLTIyMTI1_14f156a6-32c6-4af0-9711-0357a01268fd">0000771856</ix:nonNumeric><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF80L2ZyYWc6YjNmN2NlYjhmY2M0NGRlZTg3YWQwNzBiODYwYWE0ZTcvdGFibGU6NTYwYWRlMDkxMDFjNDI3YTg2MWNlZmQ1MmEyMWIxNmMvdGFibGVyYW5nZTo1NjBhZGUwOTEwMWM0MjdhODYxY2VmZDUyYTIxYjE2Y18xLTEtMS0xLTIyMTI1_289ad82b-5392-46bf-81ea-9b1beba393a4">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="csbr-20221213.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-13</xbrli:startDate><xbrli:endDate>2022-12-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i59f578f34b82470eac9b03ea5129328d_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYx_1d79b1d8-1efc-468b-99a5-414c9fd7ee93">8-K</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yNzQ4Nzc5MDcxNzU5_2b8c1350-7857-43fc-8042-2e7a3f5188d0">December 13, 2022</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYz_80a34da8-760b-4616-b37f-11ea2dbb73d5">CHAMPIONS ONCOLOGY, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.939%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6MzQyMjI5NzQzOGMyNGIyNGI1YzQ5N2RlNGEwNzFkYTIvdGFibGVyYW5nZTozNDIyMjk3NDM4YzI0YjI0YjVjNDk3ZGU0YTA3MWRhMl8wLTAtMS0xLTIyMTI1_855f4ae4-b982-47c7-b0b8-73eebe0a0787">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6MzQyMjI5NzQzOGMyNGIyNGI1YzQ5N2RlNGEwNzFkYTIvdGFibGVyYW5nZTozNDIyMjk3NDM4YzI0YjI0YjVjNDk3ZGU0YTA3MWRhMl8wLTItMS0xLTIyMTI1_aa07757c-f143-4235-9be4-888437b2cb0a">001-11504</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6MzQyMjI5NzQzOGMyNGIyNGI1YzQ5N2RlNGEwNzFkYTIvdGFibGVyYW5nZTozNDIyMjk3NDM4YzI0YjI0YjVjNDk3ZGU0YTA3MWRhMl8wLTQtMS0xLTIyMTI1_541eefed-3bc0-4ece-baa4-72c47ae9db3f">52-1401755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY1_b7db67b3-5488-468f-81e2-49833935c3bf">1 University Plaza</ix:nonNumeric>, <ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY2_488a5d91-8f32-45de-be74-b30c3d8755af">Suite 307</ix:nonNumeric>, <ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYy_f6c1ddfd-377b-458d-9479-75ea871302ef">Hackensack</ix:nonNumeric>, <ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY3_968278f2-7aed-4cfc-a6c3-c8962f17334f">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY4_681767a4-97f4-4706-8adc-a06fd243616c">07601</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl80OTg_c7d00537-755c-4117-a50a-126cece3ae5a">201</ix:nonNumeric>) <ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYw_f46a618c-faf1-46b6-9cdb-12a52f2499fc">808-8400</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address if Changed Since Last Report)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YTc1MDEzZWQyOTU4NGY2MTgwZjA2NzliODJiYzYwOGYvdGFibGVyYW5nZTphNzUwMTNlZDI5NTg0ZjYxODBmMDY3OWI4MmJjNjA4Zl8wLTEtMS0xLTIyMTI1_36538a0e-c6fd-45c2-af30-64106e50bef9">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YTQ2OWIwYmNmZGQ4NDkyYTljY2I0OWJlNjIxYjczN2YvdGFibGVyYW5nZTphNDY5YjBiY2ZkZDg0OTJhOWNjYjQ5YmU2MjFiNzM3Zl8wLTEtMS0xLTIyMTI1_5c78d878-400c-453a-9ff2-7a3ca7dccdee">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YjZmMTVjMWYzNWQzNGYwOGIxZmUxYTc4YTgxNzc3YjgvdGFibGVyYW5nZTpiNmYxNWMxZjM1ZDM0ZjA4YjFmZTFhNzhhODE3NzdiOF8wLTEtMS0xLTIyMTI1_415b5658-51a5-45ef-8470-bad8c37a8060">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YjVjOWM2MzNkOGZkNDZlYjkxOTJkOWZmZjE0MmM2MWIvdGFibGVyYW5nZTpiNWM5YzYzM2Q4ZmQ0NmViOTE5MmQ5ZmZmMTQyYzYxYl8wLTEtMS0xLTIyMTI1_ed7b285a-0d82-47ad-a55c-21c170c164e2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjcx_562999aa-dfcc-4d6b-ad1f-837d1fe323b7">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION TO BE INCLUDED IN THE REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:205.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.02.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations and Financial Condition.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2022, Champions Oncology, Inc. (the &#8220;Company&#8221;) issued a press release regarding the Company&#8217;s unaudited financial results for its fiscal quarter ended October&#160;31, 2022. A copy of the Company&#8217;s press release is attached hereto as Exhibit 99.1.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained under Item 2.02 in this Current Report shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:213.75pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:153.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="padding-left:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibit is filed herewith:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit No.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:207.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:181.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k10312022ex991xq223.htm">Press Release Dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k10312022ex991xq223.htm">December</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k10312022ex991xq223.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k10312022ex991xq223.htm">13</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k10312022ex991xq223.htm">, 2022</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHAMPIONS ONCOLOGY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 13, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ronnie Morris</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronnie Morris</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>csbr8-k10312022ex991xq223.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i95fe30c3f893472dbb5907d62cdc5687_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><img alt="logobranding_headerleftalia.jpg" src="logobranding_headerleftalia.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:666px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        NEWS</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One University Plaza, Suite 307 Hackensack, NJ 07601 Tel&#58; 551-206-8104</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Champions Oncology Reports Record Quarterly Revenue of $14.3 Million</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Hackensack, NJ &#8211; December 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, 2022</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#8211; Champions Oncology, Inc. (Nasdaq&#58; CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its second quarter of fiscal 2023, ended October 31, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Second Quarter and Recent Highlights&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Record quarterly revenue of $14.3 million, an increase of 21% year over year</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Adjusted EBITDA of $686,000</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.3pt">Discovery targets progressing along the development timeline&#59; expectation to advance to preclinical phase testing in calendar 2023</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Ronnie Morris, CEO of Champions, commented, &#8220;We continued to deliver good financial results while simultaneously investing in the future growth of the business. Morris added, &#8220;while long term prospects remain strong, we experienced a slowdown in the pace of our bookings growth during the quarter. We attribute the slow down to the global economic environment as our customers reanalyzed their spending budgets. We&#8217;re monitoring the situation closely and we&#8217;re optimistic this is a short-term adjustment as we&#8217;ve seen a re-acceleration in the beginning of our third quarter.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">David Miller, CFO of Champions, added, &#8220;We reached another revenue milestone for Champions exceeding $14 million for the first time. The increase to $14.3 million represents 21% year over year growth which was in-line with the projected growth rate for the year. However, due to the economic climate, we saw an increase in cancellations during the quarter which will impact the revenue in the second half of the year. Accordingly, we&#8217;re revising our full year growth target to be in the 10% - 15% range.&#8221;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Second Fiscal Quarter Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Total revenue for the second quarter of fiscal 2023, was a record $14.3 million, an increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.2%, </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">compared to $11.8 million for the same period last year. The increase in revenue was due to continued demand for our services, leading to larger pharmacology studies in both our in-vivo and ex-vivo platforms. Total costs and operating expenses for the second quarter of fiscal 2023 were $14.3 million compared to $11.5 million for the second quarter of fiscal 2022, an increase of $2.8 million or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.9%</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the second quarter of fiscal 2023, Champions reported income from operations of $7,000, including $119,000 in stock-based compensation and $560,000 in depreciation and amortization expenses, compared to income from </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">operations of $263,000, inclusive of $134,000 in stock-based compensation and $346,000 in depreciation and amortization expenses, in the second quarter of fiscal 2022. Excluding stock-based compensation, depreciation and amortization expenses, Champions reported adjusted EBITDA for the quarter of $686,000 compared to $743,000 in the prior year period.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Cost of oncology solutions was $7.4 million for the three-months ended October&#160;31, 2022, an increase of $1.8 million, or 32.7% compared to $5.6 million for the three-months ended October&#160;31, 2021. </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The increase in cost of sales was primarily from compensation, mice and lab supply expenses for pharmacology studies, and an increase in compensation expense for our SaaS platform. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For the three- months ended October&#160;31, 2022, total gross margin was 48% compared to 52% for the three-months ended October&#160;31, 2021. Pharmacology services margin was 51% vs 53% in the year ago period. The lower margin resulted from an increase in study related expenses against lower than expected revenue conversion. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Research and development expense for the three-months ended October&#160;31, 2022 was $2.6 million, an increase of $305,000 or 13.3%, compared to $2.3 million for the three-months ended October&#160;31, 2021. The increase was primarily from compensation and lab supply expenses related to the investment in our therapeutic discovery platform. Sales and marketing expense for the three-months ended October&#160;31, 2022 was $1.7 million, a slight increase of $60,000, or 3.7%, compared to $1.6 million for the three-months ended October&#160;31, 2021. General and administrative expense for the three-months ended October&#160;31, 2022 was $2.5 million, an increase of  $552,000, or 27.9%, compared to $2.0 million for the three-months ended October&#160;31, 2021. The increase was primarily due to depreciation and amortization expenses and IT related costs to support the growth of the business. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Net cash provided by operating activities was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$3.3 million </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">for the three months ended October 31, 2022. The cash generated from operating activities was primarily due to income from operations excluding stock-based compensation, depreciation and amortization expenses as well as an increase in accounts payable due to timing differences in the ordinary course of business. The Company ended in the quarter in a strong cash position with cash on hand of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$10.8 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> and no debt. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Year-to-Date Financial Results</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the first six months of fiscal 2023, revenue increased 21.6% to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$28.0 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$23.0 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the first six months of fiscal 2022. The increase in revenue was due to the expansion of our platforms and business lines. Total costs and operating expenses for the first six months of fiscal 2023 were </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$28.3 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$23.0 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the first six months of fiscal 2022, an increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$5.4 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or 23.3%.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the first six months of fiscal 2023, Champions reported a net loss from operations of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$277,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$325,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.1 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">expenses, compared to income from operations of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$88,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">inclusive</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$414,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$663,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization expenses, in the first six months of fiscal 2022. Excluding stock-based compensation, depreciation and amortization expenses, Champions reported adjusted EBITDA of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.1 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the first six months of fiscal 2023 compared to adjusted EBITDA of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the first six months of fiscal 2022.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Cost of oncology solutions was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$14.5 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the six-months ended October 31, 2022, an increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$3.5 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, or 31.7% compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$11.0 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the six-months ended October 31, 2021. For the six-months ended October 31, 2022, total gross margin was 48.3% compared to 52.2% for the six-months ended October 31, 2021. For the same respective periods, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">pharmacology services margin was 51.1% vs 52.8%. </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The decrease in gross margin was primarily attributable to an increase in study related expenses in advance of the revenue recognition and lower than expected revenue conversion.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Research and development expense for the six-months ended October 31, 2022 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$5.5 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, an increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$888,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or 19.3%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$4.6 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the six-months ended October 31, 2021. The increase was primarily from compensation, sequencing costs, and lab supplies as we increased investment in our therapeutic target discovery platforms. Sales and marketing expense for the six-months ended October 31, 2022 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$3.4 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a slight increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$178,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, or 5.5%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$3.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the six-months ended October 31, 2021. General and administrative expense for the six-months ended October 31, 2022 wa</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">s $4.9 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, an increase of $800,000, or 19.3%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$4.1 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the six-months ended October 31, 2021. The </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">increase</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> was primarily due to an increase in compensation and IT related expenses to support the overall infrastructure growth of the organization as well as depreciation and amortization expenses.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Net cash provided by operating activities was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$3.1 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the six-months ended October 31, 2022. The cash generated from operating activities was primarily due to an increase in income from operations excluding stock-based compensation and depreciation and amortization expenses as well as an increase in accounts payable due to timing differences in the ordinary course of business. Net cash used in investing activities was $1.4 million and was primarily from investment in additional lab and computer equipment.</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conference Call Information&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company will host a conference call today at 4&#58;30 p.m. EST (1&#58;30 p.m. PST) to discuss its second quarter financial results. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To participate in the call, please call 877-545-0523 (Domestic) or 973-528-0016 (International) and enter the access code 541646, or provide the verbal reference &#34;Champions Oncology&#34;.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Full details of the Company&#8217;s financial results will be available by December 15, 2022 in the Company&#8217;s Form 10-Q at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#333366;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">www.championsoncology.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">* Non-GAAP Financial Information</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">See the attached Reconciliation of GAAP net income (loss) to Non-GAAP net income for an explanation of the amounts excluded to arrive at Non-GAAP net income and related Non-GAAP earnings per share amounts for the three and six months ended October&#160;31, 2022 and 2021. Non-GAAP financial measures provide investors and management with supplemental measures of operating performance and trends that facilitate comparisons between periods before and after certain items that would not otherwise be apparent on a GAAP basis. Certain unusual or non-recurring items that </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">management does not believe affect the Company&#8217;s basic operations do not meet the GAAP definition of unusual or non-recurring items. Non-GAAP net income and Non-GAAP earnings per share are not, and should not, be viewed as a substitute for similar GAAP items. Champions defines Non-GAAP dilutive earnings per share amounts as Non-GAAP net earnings divided by the weighted average number of diluted shares outstanding. Champions&#8217; definition of Non-GAAP net earnings and Non-GAAP diluted earnings per share may differ from similarly named measures used by other companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Champions Oncology, Inc.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Champions Oncology is a technology-driven research organization that develops innovative therapeutics against cancer targets, offers groundbreaking research software as a service, and provides end-to-end R&#38;D services to biopharma organizations. Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration. For more information, please visit www.ChampionsOncology.com.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">This press release may contain &#34;forward-looking statements&#34; (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.  Champions Oncology generally uses words such as &#34;believe,&#34; &#34;may,&#34; &#34;could,&#34; &#34;will,&#34; &#34;intend,&#34; &#34;expect,&#34; &#34;anticipate,&#34; &#34;plan,&#34; and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2022 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i95fe30c3f893472dbb5907d62cdc5687_4"></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Champions Oncology, Inc.</font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in thousands)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Net Income (Loss) (Unaudited)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>October 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br>October 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) - GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) - Non-GAAP</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP EPS to Non-GAAP EPS (Unaudited)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>October 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br>October 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211; GAAP, basic</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock-based compensation on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS - Non-GAAP, basic</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>October 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br>October 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211; GAAP, diluted</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock-based compensation on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS - Non-GAAP, diluted</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Operations (unaudited)</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>October 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br>October 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology services revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,281&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,786&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,026&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,039&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology services</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,443&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,609&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,495&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,005&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,604&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,491&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,603&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,975&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,925&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(277)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before provision for income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">277</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(335)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income (loss) per common share outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,528,643&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,428,508&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,521,496&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,145,930&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,528,643&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,549,136&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,521,496&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,213,450&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.807%"><tr><td style="width:1.0%"></td><td style="width:65.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 31, 2022</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(unaudited)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,826&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,948&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,513&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,608</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,664</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,698&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,230&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,708&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,134&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,364</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,378</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,275&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,282&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,071&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,736</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,479</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,832&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,412&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non-current Liability</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,192&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,282&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,172&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,096&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,364</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,378</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Cash Flows (unaudited)</font></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br>October 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operations&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on disposal of equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,091</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,444</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,473)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities&#58;</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,358)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,473)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by financing activities&#58;</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash at beginning of period</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,687&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash at the end of period</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,826</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,781</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>csbr-20221213.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e4f48ed9-bbba-4e3a-9c1a-65b15a67e884,g:7ce3ad52-b33f-47e4-9b03-96c1a17d6b6c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:csbr="http://championsoncology.com/20221213" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://championsoncology.com/20221213">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20221213_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20221213_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://championsoncology.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>csbr-20221213_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e4f48ed9-bbba-4e3a-9c1a-65b15a67e884,g:7ce3ad52-b33f-47e4-9b03-96c1a17d6b6c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_85ec61f7-f8cc-4b52-908b-f526cd608ab3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_6c4a6c1d-681d-476a-aa2e-022347155181_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_15f92c1c-9373-4d8d-8f49-2a07ba562d95_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_794adcd7-1a83-4bcc-86f3-60e153ac1dd6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_33f61a51-6ea6-448a-ac0e-79c9798d3b4d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_9b3a1cad-91d0-4c46-b884-0bdf5f6e5bdb_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_1ebb73ae-c05a-478b-9ebf-92b2288f941c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_36f083d7-3e02-4ec1-8c0a-f53c8a955ef4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5c5e4ddd-539e-4e8a-8c6a-f34f6cbc8c9c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7ed35ccb-644a-4820-954b-41d0e1cea530_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_417d5cb0-f8c6-4dea-a94f-33df66e9eb25_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5fed52a9-98bf-4031-bb46-e223841a3260_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c536f745-1db9-454d-8591-af430986d294_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_71b88065-202a-4e24-91da-07e41ec742dc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6b889bbd-7cc0-457a-96f4-9f6896f175df_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a5025418-8475-42b9-9026-ea1e81ed84f1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_456a88be-2e6c-4c48-bdbe-94e54f490800_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4f7e4e02-480c-42d8-a98f-517f52ad12b4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_473bb93d-77b8-484b-a9ed-ce806d6f368b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ca3f39cd-0463-4827-b9f8-7b539216018c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>csbr-20221213_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e4f48ed9-bbba-4e3a-9c1a-65b15a67e884,g:7ce3ad52-b33f-47e4-9b03-96c1a17d6b6c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://championsoncology.com/role/CoverPage" xlink:type="simple" xlink:href="csbr-20221213.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ab7dab84-e95a-4da0-bf6b-f70e8bec4458" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_DocumentType_ab7dab84-e95a-4da0-bf6b-f70e8bec4458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_80b90a77-0bf3-4b66-a0db-302092d0a2f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_DocumentPeriodEndDate_80b90a77-0bf3-4b66-a0db-302092d0a2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_099f54b2-b777-4ffc-9ce7-1b40948a1fa8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityRegistrantName_099f54b2-b777-4ffc-9ce7-1b40948a1fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_450bc551-0b7a-43f2-9280-b257a97228c2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_450bc551-0b7a-43f2-9280-b257a97228c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_57d2afc9-8126-438b-acf1-c7d375adf7d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityFileNumber_57d2afc9-8126-438b-acf1-c7d375adf7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c419a9cf-ae0b-4e79-8008-3e54084600ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityTaxIdentificationNumber_c419a9cf-ae0b-4e79-8008-3e54084600ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_cbb587c6-ab35-40c2-a35a-8245d6c6cada" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityAddressAddressLine1_cbb587c6-ab35-40c2-a35a-8245d6c6cada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_970dd170-fbd0-4904-a8a5-7bb7306717d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityAddressAddressLine2_970dd170-fbd0-4904-a8a5-7bb7306717d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d363c4c7-3c40-442b-8af3-cd52a8dfffd3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityAddressCityOrTown_d363c4c7-3c40-442b-8af3-cd52a8dfffd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c11afefb-57fa-4531-9bdd-1a84d8f07051" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityAddressStateOrProvince_c11afefb-57fa-4531-9bdd-1a84d8f07051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ef49bbd7-3e5a-4249-8491-6d0b30e6828b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityAddressPostalZipCode_ef49bbd7-3e5a-4249-8491-6d0b30e6828b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bfde4f78-0621-4a88-b598-55356190f901" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_CityAreaCode_bfde4f78-0621-4a88-b598-55356190f901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1e4433db-b15c-4519-9b06-3fb56af10a14" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_LocalPhoneNumber_1e4433db-b15c-4519-9b06-3fb56af10a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_07d27316-ff66-4649-875b-899952885027" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_WrittenCommunications_07d27316-ff66-4649-875b-899952885027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_542b803d-49e2-406d-8ed0-459d20e5358b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_SolicitingMaterial_542b803d-49e2-406d-8ed0-459d20e5358b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_335fc9d7-e2c0-4690-afec-68519fa9bc40" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_PreCommencementTenderOffer_335fc9d7-e2c0-4690-afec-68519fa9bc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_bdf920fa-d322-4a04-bc44-a7a654c98a77" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_bdf920fa-d322-4a04-bc44-a7a654c98a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3d3971b7-dc91-4c11-8403-f26c99074acd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityEmergingGrowthCompany_3d3971b7-dc91-4c11-8403-f26c99074acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b82834bd-f243-45c0-84cf-b031610fbbb7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_EntityCentralIndexKey_b82834bd-f243-45c0-84cf-b031610fbbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_21c7b7eb-4d53-4596-b589-7e06a4d6bb31" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4b8a4ef-feaa-4c87-90c7-6d3fcb4d084e" xlink:to="loc_dei_AmendmentFlag_21c7b7eb-4d53-4596-b589-7e06a4d6bb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logobranding_headerleftalia.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logobranding_headerleftalia.jpg
M_]C_X0E@17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    A    <@$R  (    4
M    DX=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C$@*$UA8VEN=&]S:"D ,C R,#HP-3HQ-" Q,#HU-SHT,P
M  .@ 0 #     ?__  "@ @ $     0   S2@ P $     0   5X
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   ()@        !(     0   $@
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MJ22GZJ27RJDDI^JDE\JI)*?_V?_M$>Q0:&]T;W-H;W @,RXP #A"24T$)0
M    $                      X0DE-!#H      0L    0     0
M"W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT
M97).86UE5$585    !0 0P!A &X ;P!N "  5 !2 #@ -0 P #  ( !S &4
M<@!I &4 <P      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\
M9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M
M$     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L
M      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#
M;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O
M;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'0D,    #
M     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^            !"
M;" @9&]U8D!OX            $)R9%15;G1&(U)L=                $)L
M9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M"G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M    3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M        4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN
M9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,
M969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!2
M96-T5&]P;&]N9P      .$))30/M       0 2P    !  $!+     $  3A"
M24T$)@      #@             _@   .$))300-       $    6CA"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8
M 0"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M     3A"24T#^       <   _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H   X0DE-!
M      ( "SA"24T$ @      &                                #A"
M24T$,       # $! 0$! 0$! 0$! 3A"24T$+0      !@ !    ##A"24T$
M"       $     $   )    "0      X0DE-!!X       0     .$))300:
M      .+    !@             !7@   S0    K $P ;P!G &\ ( !" '(
M80!N &0 :0!N &< 7P!( &4 80!D &4 <@ @ $P 90!F '0 ( !! &P :0!G
M &X 90!D "  =P!I '0 :  @ $< <@!I &0    !
M      $              S0   %>                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     PX0DE-! P     "$(    !    GP
M $0   '@  !_@   ""8 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( $0 GP,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MI>3JS^3_ )Z;PR[+N(=V\DL\=:Q-99<($NBI[@/:VR/4J;94_P!KO\&]^_\
MP:MX][<BH6L:YK73 >TL=II]!\/2((W"@0=BE22202I))))3_]+U5))))2DD
MDDE*3$ B#J"G224I))))2DT"9[ITDE*30)GNG224M ^Y.DDDI22222E))))*
M4DDDDI__T_54E\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?_V3A"24T$(0
M5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0
M00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #  ,@ P     0 X
M0DE-! 8       < ! $!  $! /_A$BQH='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#8N,"UC,# R(#<Y+C$V
M-#,U,BP@,C R,"\P,2\S,"TQ-3HU,#HS." @(" @(" @(CX@/')D9CI21$8@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS
M>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS
M=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U
M<F-E179E;G0C(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL;G,Z<&AO=&]S:&]P/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(B!X;7 Z0W)E871O
M<E1O;VP](D%D;V)E(%!H;W1O<VAO<" R,2XQ("A-86-I;G1O<V@I(B!X;7 Z
M0W)E871E1&%T93TB,C R,"TP-2TQ-%0Q,#HU-SHP,RTP-SHP,"(@>&UP.DUE
M=&%D871A1&%T93TB,C R,"TP-2TQ-%0Q,#HU-SHT,RTP-SHP,"(@>&UP.DUO
M9&EF>41A=&4](C(P,C M,#4M,314,3 Z-3<Z-#,M,#<Z,# B(&1C.F9O<FUA
M=#TB:6UA9V4O:G!E9R(@>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#IE.65A
M9C0R-"UC,F,U+30U-#4M.#1B,2TW931F9C$T,&(R,#@B('AM<$U-.D1O8W5M
M96YT240](F%D;V)E.F1O8VED.G!H;W1O<VAO<#IE9#5A-SAF."TR93=A+60P
M-#@M8C$Q."UC-3AD,F$U9&1D,V$B('AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#TB>&UP+F1I9#HR-SDT8C1D,BUC.34T+30T-S8M83$X.2TS-#4R-CDP.#(Y
M-V,B('!H;W1O<VAO<#I#;VQO<DUO9&4](C,B/B \>&UP34TZ2&ES=&]R>3X@
M/')D9CI397$^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)C<F5A=&5D(B!S=$5V
M=#II;G-T86YC94E$/2)X;7 N:6ED.C(W.31B-&0R+6,Y-30M-#0W-BUA,3@Y
M+3,T-3(V.3 X,CDW8R(@<W1%=G0Z=VAE;CTB,C R,"TP-2TQ-%0Q,#HU-SHP
M,RTP-SHP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@4&AO=&]S:&]P
M(#(Q+C$@*$UA8VEN=&]S:"DB+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](G-A
M=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7 N:6ED.C%E-30Y-S0V+3(S-&,M
M-&%B8BTY-SDT+68R-34Y-V(Q-S@S9B(@<W1%=G0Z=VAE;CTB,C R,"TP-2TQ
M-%0Q,#HU-SHT,RTP-SHP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@
M4&AO=&]S:&]P(#(Q+C$@*$UA8VEN=&]S:"DB('-T179T.F-H86YG960](B\B
M+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](F-O;G9E<G1E9"(@<W1%=G0Z<&%R
M86UE=&5R<STB9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P
M('1O(&EM86=E+VIP96<B+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](F1E<FEV
M960B('-T179T.G!A<F%M971E<G,](F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T
M:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O:G!E9R(O/B \<F1F
M.FQI('-T179T.F%C=&EO;CTB<V%V960B('-T179T.FEN<W1A;F-E240](GAM
M<"YI:60Z93EE868T,C0M8S)C-2TT-30U+3@T8C$M-V4T9F8Q-#!B,C X(B!S
M=$5V=#IW:&5N/2(R,#(P+3 U+3$T5#$P.C4W.C0S+3 W.C P(B!S=$5V=#IS
M;V9T=V%R94%G96YT/2)!9&]B92!0:&]T;W-H;W @,C$N,2 H36%C:6YT;W-H
M*2(@<W1%=G0Z8VAA;F=E9#TB+R(O/B \+W)D9CI397$^(#PO>&UP34TZ2&ES
M=&]R>3X@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM
M<"YI:60Z,64U-#DW-#8M,C,T8RTT86)B+3DW.30M9C(U-3DW8C$W.#-F(B!S
M=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED.C(W.31B-&0R+6,Y-30M-#0W-BUA
M,3@Y+3,T-3(V.3 X,CDW8R(@<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/2)X
M;7 N9&ED.C(W.31B-&0R+6,Y-30M-#0W-BUA,3@Y+3,T-3(V.3 X,CDW8R(O
M/B \<&AO=&]S:&]P.E1E>'1,87EE<G,^(#QR9&8Z0F%G/B \<F1F.FQI('!H
M;W1O<VAO<#I,87EE<DYA;64](D-R96%T:6YG($=R96%T97(@0V5R=&%I;G1Y
M($EN('1H92!&:6=H="!!9V%I;G-T($-A;F-E<B(@<&AO=&]S:&]P.DQA>65R
M5&5X=#TB0W)E871I;F<@1W)E871E<B!#97)T86EN='D@26X@=&AE($9I9VAT
M($%G86EN<W0@0V%N8V5R(B\^(#QR9&8Z;&D@<&AO=&]S:&]P.DQA>65R3F%M
M93TB0W)E871I;F<@1W)E871E<B!#97)T86EN='D@26X@=&AE($9I9VAT($%G
M86EN<W0@0V%N8V5R(&-O<'DB('!H;W1O<VAO<#I,87EE<E1E>'0](D-R96%T
M:6YG($=R96%T97(@0V5R=&%I;G1Y($EN('1H92!&:6=H="!!9V%I;G-T($-A
M;F-E<B(O/B \+W)D9CI"86<^(#PO<&AO=&]S:&]P.E1E>'1,87EE<G,^(#PO
M<F1F.D1E<V-R:7!T:6]N/B \+W)D9CI21$8^(#PO>#IX;7!M971A/B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0](G<B/S[_[@ A061O
M8F4 9      ! P 0 P(#!@               /_; (0 !@0$! 4$!@4%!@D&
M!08)"P@&!@@+# H*"PH*#! ,# P,# P0# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# $'!P<-# T8$! 8% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,_\( $0@!7@,T P$1  (1 0,1
M ?_$ 0$  0 " P$! 0             %!P0&" ," 0$!  (# 0
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M$0   .J0
M
M
M
M
M
M
M
M    "/WTU&Q6C=],_3?;J]B3TD
M             &EV:O/G7X]<7*7QG 'UA8E.[T#R>QO56V
M                               !1O4Y7.G8XOGG   'UA?G*Z_0?([(
M                                            %)=/E<U]KB #TQF3
MTWCM]/'. )Z&;L[SGII6.0
M     #59Z_%WI?,>.<"1TWZ*X_:MSG]'*UV\,XJR_P _G'L<7UQGL'SWI-BA
MF                                            '+/=X%2=#G#.TW[
M'\[Z7;*]@ " EA^,MBAF
M    'EG'!WJO)8FVHZ.XW:O/E]8:39JT[T>9LL,]W\SJ^F,@1N^DCIN/C./3
M&?+./7&1B;:Y>NP\<X]L9^,X \F/?&WZ>.<>V,B/WTS==OO&?/./O&1\9QZ8
MSC;:^N,^F,@                           :Q/!Q+Z;RP'<WE_5S<4L/)
M%Q#Z?RV)MJ+^Y/7Z#Y'9^,XY.[WGO3&9/3>[>9U:7Z?+Z(X_:Y6[OG^N?/\
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M_5+%?ZPJ^]0W6M:R]=K6H=#FCM<.SJ5[H#D]C[QD
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M_:J]BQJ=W2[-67CD^F8"6':H+%47^?*1[VG1Z
M      YG[7#I;I\L>^N>N?/^CL&I<  TZS6^&-TK6@  /+.*:Z7,VVO8CM])
M'3?8X9ZEO\ZT:-^L;U&QJ5V/WTWNK;IOH\R<CEEHY-%M5=QK6?S+9X)Y6.0
M                              ""EAXI]+YC!WT'MC-Y\OK6[S^C/0RP
MTL=3W^=0_5Y/MC/7/G_1[O5M  #2[-6#EBTVS5QLXKZW3MWG]&T:-^O;E/<:
MUFK[U#,UVM>AT:QNT(:6+ZQF;CEL&G<H7K<CI_A]X
M             "KKU#E/O>?\\X    S]-^W/,^IEHY  !5-_G[C7L^3&-MKL
MT$]67Z%ETKU;7*-C4[VC6JD]%+#21SD4LAKOH=JI:]#H:U-!M4%@
M                         5A>H<N=S@X&^@  &7KMTOQ>Y;_.Z0
M                                       $-)%1'5Y-37^=#RQ@2D<E
MK4.A?'*ZT_%,                                               !
M"RQ8.VF9KO-Q2_H
M
M                                              ,?.,C&0
M,?.,C&0  //./P]<9 Q\X]\9\,ZY&-@ ,?.,C&0
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MBEV:&8
M
M
M
M
M
M
M
M
M
M
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M%F*WH#0D\9$@I*G*?EYIX@5K)"N@> O ;HCIW)"FG7S<7S"+QIK[ES1/FO\
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M.,BHW\85-.!TEPQC_%QH30L6VNF83;:\7XP.Z_*ATQ#!O3K:&,>&+2DG-&(
MME(CHZD>.+2:>QX.%T?A8@"V6I$='4CQT:&3%1W3#*-CP7'BIZ>8%Q%Q0Z9@
M-@NI,47=,,HV+S(N#&ABTKC8FAXL%TUCFP7XUDV>1<!)46)+1U/#)E"TD64+
MJ>-51$7($2QI@NZ>G(VY+E>DCSPMC^8GI'Q]/\Q-=1Y(NHS)ZW-'D%4HTU'%
MDRA:1)YHLJ032/3!!MHB(?(+[*. 8**\$)45C)JF@EM%KK'1RFQT_D]$:DK;
MB@L64+J>*:BJUCS'T@5"E26D<D/&:#E47I%T.C(KU,QG ].!_-Z*O*0]_,,6
M8]#ZH4F4J#(F.NAH4]1J+'YN^0YL3U$5.7\(#459(B'Q.8ULE8C TBQA5R1$
M!W1@A)^5M\Q:%!+&-JK3(MHYCFR*/$%K3N/;-6(@-:>8%Q!QC:*B(B-QA _(
MDN$CFC;(%\8@I+$@('EYUD7$>QA)HV3#P T1:9QA+IE@&T\PDP"Z^U:T+#:?
MY,B)$3_ D2(GC541$5%3BA(O 20D\*DB?&G3Z1:C"X*OFKCLY45QX^HI)DR9
M&B.23ZCE*@1'3<1U>MQEQL&UDD(,RE4ONG-=;A/.SE17'SZS-1!J,+@NS513
MD%U.&\KCD@^I7B(7))HKSQD/KD)QS(A;+Z@27%T^:@!DX,=ETA(9Q$3Y](0V
M@30R5%I))J$<S!6#<-R2]Z80N0D$QPR.4>E<52.6?)^00E)<<YHJH++"/";Q
M(7W1]#<DN;3KBHW-(B1\R/X<8H2-,$"M,]"A#Z3<C*I'%Y@K',_MEZ9*IU1E
M)0=CJI+#^F^PC@MQ^0-Q%10847 A])@SR,Q0D:8(%^SY&C/U%87U'(BDOVZ=
M2Q5Z'8ZDKJ(\YI(O)O[=.I]KU *.I#Z'XH\56UD,^H#@=0R>0HVV3K7H_498
M4%<80S<;1K4->1%!YZ]'ZGVGTWHQ.*XPI$J::C$"N1%4OMTYI&_D#"H,>*K:
ML,]"?[5/_]H " $!  $% /\ 6[RUBP&'";OOM9$+_L=MGJ'OWM9*+#VBN9H?
M,%^W9J=,;M^_U\SY////N\6G7&G*COS?J^=!WCJ-Q\O;P;]#C3???D/>-MPV
MSVCW_<1P20D\M;^;N'B6O Q'D2'!IUN(9,.7%<XTNEYNWYNJ5YJNU[RSN;=V
M:;4I<N3,E<,!7LS8,I1>VZO8YK&XG%8N/J; @SF+MVZ5+,MVJHYZK96ETO-V
M_-T6BX2FX3RUW'VX\K<^&#PF2SF6VXVZQ%)PGANE)P=OPU%HN$IN$\M2I+,6
M+E\E(RF5X=LM*;CXOAN'NU6*2$WNEMYOU+N>QTN5%E1I<?B[9JVT^!@8&8 +
M4J,\JJB(W,B.GHB04C9?$RG=*J(@38;AZ=D,,Z:>9>%V0PSK\QQ^@,#'2S8:
M'PEV' 0WF7F7VM.R([.@<!P#<!L&I,9Y=2LIC(AQY,>2U\9W/F%#V[XT?$AB
M*=JXV-FMU?*Y2?ELEP[9+O)61IYYIAG<K=NR7;,1NW#<IZ!LWB=U</?-W_VS
M[6O[OL/Z!V]?NGK?BW_\=H5.L4FLV>)+CS(EA_0,?D)F.GT"\X^V5+=_<!RY
MVOM=_L#NL_3ZEL[=+5AR/</:ZQ4ZR,66L9'][M;R;U9C)Y;#]O.Y&4@MR=Q=
MK;#M[=H-RK'=?K8/=-*_D=[?VL[5_P!?WNO$^HTRE[5W7<)G$;;[PU6W,BX+
M7QC>@72VOXL$T3.M_P!EYS:OCV]LON;J:WCEO1=L>V;&0I=]URUN_P#MG2[U
MGZ=/E=PVX\J+V]?NGK?RTN63<#>6D8#&4;MPM_YO3;#^@;=U(+;9&,Y:JLSE
M:!)Q.W7:[_8'=9^G[.[Q4NJTO>?<B#>,[M+@IF"VZR/[W6Z9(@U38G%PLCN=
MKN3Q4&5M[VIRW^KNOU-V\FIMUCMU/SW9WM7_ %_>2AR[G3\9GMR-N)]/[GGR
MDQY#,ACXQN/ *?0>.W&:#-436:Q$/,8B[TK,5#/:1.>NWG;697\=JS8)C/5Z
MOYBP[9WR-W%[9.P*QW'Q,Q=MW_VS[7V&7K=8,? 3 ]O7[I[@6EJK5"E;>VB^
M2_\ K/N-K:C/RZ/N;8?T#MZ_=.^[*8JUW'NA;;:IG:[_ &!W6?I^TVR%4N%/
MJ6Q] K4O61_>Z5&9E1<OC+%MG?L)W'[=S8&\V\0W5>WZC2ZU4^Z_6PL2-,VB
MW:VVDTFP]J_Z_NUN:Q1<)@^X?;O-8W=:?0YUIVTAS(>W_P 8=;;=;LF'=PM@
MX=LMZ;;+A8:S@;% F]L%%>?J.R=!K$KC=MM:E<FC[5<,K]&VAIM.<L^ C6'
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MHDB7:2VLD+A=Q7\:SG=KIF;ETBR;;SY=G=V:;<H]]HD"WURO[;.0*U@=H,A
MRF%H,_$7?$;++A[-B:8L&[YC%0LOBJCM_9Z](795(]K8I8AN#*H,]=PL[LY-
MGY =N8XV ]I7UJ]EVSD9&?:H>.W-W!   (VU+D>BKMTPN?O=2:MM5R.V^4RV
M&';V.]9J'M+)J64W!IY6^LV+!KE:SN)]AAF:[6<W>=L$I*+?Z)09]3F9W;Z)
MG[=;:XU11V>D%'MF0V+D28Z4?E?1V:_]!NNVF:M4BR[<R\CGGV&I#%:VQL%;
MD9_:"9D,P.V; Y.-M;&+'X&@9>/@J!M5)J.0HE+&JP_]JG__V@ ( 0("!C\
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M3@N/8.;E3'+XN+SQ*QAE87X%I9814GD>,5A/WK,5;(_?_DR86_X)A;[!@F/
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M-RAM/*Z[9(GT]A_%P+,MNQ!8V@M2:O(TH.G=N4-%_P!9PF*EQKU\-=9*^/F
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MTET]B9*=')YMEFL;)9^R6KI++$7C ;Y3M&]U^)*NY=JINW?.9KDM>K5C-?\
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M9:%J[&K2K8Z.)'5U)CBKC9O/,W;FW>7CIRWD>I9LG6Z:YJT:+5HX8Q&\>R(
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M2,F8,B'("_D[AK^*R-Y<Q[.;\,MX/B;Y/)Y>)ZMCJ:2#IJRT;RX84Z\C*T8
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EBUFL,H/>[<9&)K?SUG)WYLA8L<OE>*;3PA=\G8NWVO\ W53_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140528548828432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Dec. 13, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 13,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHAMPIONS ONCOLOGY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1401755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 University Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hackensack<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">808-8400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000771856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>csbr-20221213_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="csbr-20221213.xsd" xlink:type="simple"/>
    <context id="i8141a47da7494ecbb1d595463553e157_D20221213-20221213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <startDate>2022-12-13</startDate>
            <endDate>2022-12-13</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF80L2ZyYWc6YjNmN2NlYjhmY2M0NGRlZTg3YWQwNzBiODYwYWE0ZTcvdGFibGU6NTYwYWRlMDkxMDFjNDI3YTg2MWNlZmQ1MmEyMWIxNmMvdGFibGVyYW5nZTo1NjBhZGUwOTEwMWM0MjdhODYxY2VmZDUyYTIxYjE2Y18wLTEtMS0xLTIyMTI1_14f156a6-32c6-4af0-9711-0357a01268fd">0000771856</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF80L2ZyYWc6YjNmN2NlYjhmY2M0NGRlZTg3YWQwNzBiODYwYWE0ZTcvdGFibGU6NTYwYWRlMDkxMDFjNDI3YTg2MWNlZmQ1MmEyMWIxNmMvdGFibGVyYW5nZTo1NjBhZGUwOTEwMWM0MjdhODYxY2VmZDUyYTIxYjE2Y18xLTEtMS0xLTIyMTI1_289ad82b-5392-46bf-81ea-9b1beba393a4">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYx_1d79b1d8-1efc-468b-99a5-414c9fd7ee93">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yNzQ4Nzc5MDcxNzU5_2b8c1350-7857-43fc-8042-2e7a3f5188d0">2022-12-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYz_80a34da8-760b-4616-b37f-11ea2dbb73d5">CHAMPIONS ONCOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6MzQyMjI5NzQzOGMyNGIyNGI1YzQ5N2RlNGEwNzFkYTIvdGFibGVyYW5nZTozNDIyMjk3NDM4YzI0YjI0YjVjNDk3ZGU0YTA3MWRhMl8wLTAtMS0xLTIyMTI1_855f4ae4-b982-47c7-b0b8-73eebe0a0787">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6MzQyMjI5NzQzOGMyNGIyNGI1YzQ5N2RlNGEwNzFkYTIvdGFibGVyYW5nZTozNDIyMjk3NDM4YzI0YjI0YjVjNDk3ZGU0YTA3MWRhMl8wLTItMS0xLTIyMTI1_aa07757c-f143-4235-9be4-888437b2cb0a">001-11504</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6MzQyMjI5NzQzOGMyNGIyNGI1YzQ5N2RlNGEwNzFkYTIvdGFibGVyYW5nZTozNDIyMjk3NDM4YzI0YjI0YjVjNDk3ZGU0YTA3MWRhMl8wLTQtMS0xLTIyMTI1_541eefed-3bc0-4ece-baa4-72c47ae9db3f">52-1401755</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY1_b7db67b3-5488-468f-81e2-49833935c3bf">1 University Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY2_488a5d91-8f32-45de-be74-b30c3d8755af">Suite 307</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYy_f6c1ddfd-377b-458d-9479-75ea871302ef">Hackensack</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY3_968278f2-7aed-4cfc-a6c3-c8962f17334f">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjY4_681767a4-97f4-4706-8adc-a06fd243616c">07601</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl80OTg_c7d00537-755c-4117-a50a-126cece3ae5a">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjYw_f46a618c-faf1-46b6-9cdb-12a52f2499fc">808-8400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YTc1MDEzZWQyOTU4NGY2MTgwZjA2NzliODJiYzYwOGYvdGFibGVyYW5nZTphNzUwMTNlZDI5NTg0ZjYxODBmMDY3OWI4MmJjNjA4Zl8wLTEtMS0xLTIyMTI1_36538a0e-c6fd-45c2-af30-64106e50bef9">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YTQ2OWIwYmNmZGQ4NDkyYTljY2I0OWJlNjIxYjczN2YvdGFibGVyYW5nZTphNDY5YjBiY2ZkZDg0OTJhOWNjYjQ5YmU2MjFiNzM3Zl8wLTEtMS0xLTIyMTI1_5c78d878-400c-453a-9ff2-7a3ca7dccdee">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YjZmMTVjMWYzNWQzNGYwOGIxZmUxYTc4YTgxNzc3YjgvdGFibGVyYW5nZTpiNmYxNWMxZjM1ZDM0ZjA4YjFmZTFhNzhhODE3NzdiOF8wLTEtMS0xLTIyMTI1_415b5658-51a5-45ef-8470-bad8c37a8060">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGFibGU6YjVjOWM2MzNkOGZkNDZlYjkxOTJkOWZmZjE0MmM2MWIvdGFibGVyYW5nZTpiNWM5YzYzM2Q4ZmQ0NmViOTE5MmQ5ZmZmMTQyYzYxYl8wLTEtMS0xLTIyMTI1_ed7b285a-0d82-47ad-a55c-21c170c164e2">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8141a47da7494ecbb1d595463553e157_D20221213-20221213"
      id="id3VybDovL2RvY3MudjEvZG9jOjU5ZjU3OGYzNGI4MjQ3MGVhYzliMDNlYTUxMjkzMjhkL3NlYzo1OWY1NzhmMzRiODI0NzBlYWM5YjAzZWE1MTI5MzI4ZF8xL2ZyYWc6ZTI1MTk2ZDg3OWQ4NDYzMWE2YzEzNzZhNGViMTEyMWIvdGV4dHJlZ2lvbjplMjUxOTZkODc5ZDg0NjMxYTZjMTM3NmE0ZWIxMTIxYl8yMjcx_562999aa-dfcc-4d6b-ad1f-837d1fe323b7">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MC@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( "N
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M"@.4;ZH5E=>2BBTGW='K3.\?)H]:1NO<2KGW\$JV''..?[3\ 5!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    "  K@(U5!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "N C55]
MY5!%[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( "N C5697)PC$ 8  )PG   3              "  <L!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ *X"-52P[B1'T P
M4@\  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( "N C56?H!OPL0(  .(,   -              "  38,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ *X"-59>*NQS     $P(   L
M             ( !$@\  %]R96QS+RYR96QS4$L! A0#%     @ *X"-51E%
M%?4W 0  )P(   \              ( !^P\  'AL+W=O<FMB;V]K+GAM;%!+
M 0(4 Q0    ( "N C54D'INBK0   /@!   :              "  5\1  !X
M;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "N C55ED'F2
M&0$  ,\#   3              "  402  !;0V]N=&5N=%]4>7!E<UTN>&UL
64$L%!@     )  D /@(  (X3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="csbr-20221213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="csbr-20221213.htm">csbr-20221213.htm</File>
    <File>csbr-20221213.xsd</File>
    <File>csbr-20221213_lab.xml</File>
    <File>csbr-20221213_pre.xml</File>
    <File>csbr8-k10312022ex991xq223.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "csbr-20221213.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "csbr-20221213.htm"
     ]
    },
    "labelLink": {
     "local": [
      "csbr-20221213_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "csbr-20221213_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "csbr-20221213.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 21,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 20,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "csbr",
   "nsuri": "http://championsoncology.com/20221213",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20221213.htm",
      "contextRef": "i8141a47da7494ecbb1d595463553e157_D20221213-20221213",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://championsoncology.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20221213.htm",
      "contextRef": "i8141a47da7494ecbb1d595463553e157_D20221213-20221213",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r4": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-22-031796-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-031796-xbrl.zip
M4$L#!!0    ( "N C55#?@+-0!0  #:B   1    8W-B<BTR,#(R,3(Q,RYH
M=&WM/6U7VLK6W^^OF(>SGGO;M3J0R7NH]2XKZ*''A(JQ'/CBFB03"":$DP1Y
M^?5W3P)6%*VVM8+%M53"O.T]>\]^FYV9O?].HQ!=L20-XN&'$BD+)?3?_;W_
MP_COCZT35(O=<<2&&3I,&,V8AR9!UD=MCZ67R$_B"+7CY#*XHACG;0[CT2P)
M>OT,B8(HWBI,JDSV99UY!G8<AV*9210;+J%851RB4%5CNBZ_ZU4U%TH\1<2.
M)/E8UIB,#4>0L*%"9:)YJJ.Z[[RJ8OB*ION2[.BBK F,NKP6HPH1#4G4/3YL
M/P/L ,-A6@V#X>6'4C_+1M5*93*9E*=.$I;CI%<1!4&J\&*'IJRTJ#Y-@Y7:
M$VE9EU3^-D_.W#Z+* Z&:4:'[G4KCWUME?>?,K?<BZ\J4%#A<[*HN*YK8AA&
M9<HA7O863+/U$ =# )=Q"E6RA Y3/TXBF@$%^1@"%D1,Q*^=W(<UD6YT=(TW
ME </S--MC %&#$BNM%@B_1"81,&"CB5R/>X=^JQ,"R_-JU9#.NQ]*+$A/C\K
M 8$9]?;W(I91Q)MB]L\XN/I0.HR'&; MMF<C@-0MGCZ4,C;-*OD,5_;_]:]_
M[65!%K)]-W42S(E#1"+M58HO]RI%UT[LS?;WO. *I=DL9!]*7I".0CJK#N,A
M P"":9579$GQ,? \-LP_0KD%:R<)W&+\:=9B_H=2H!.94%GSJ"8;,G,=AWB*
MH<BJI"@2(XIV45N"<@U3"0UIQ(=F0;4^!/AFAX!.0L/&T&/3O]BLA (/NO:D
M+S.G%E^=B*VKCF2.O4']JGML#)J#<Z4[.)>:QYVY==R0S<&I9!Y_Z7?F86#6
MK+!CGT_-P>7<'/0O3R1XGL>DV>X0:]Z/S'DK:-8:@C7_&';:IM(9',R[[3HQ
M[89BSAMR]T@73L3NK--VU<[ BBP1V@_Z44<T!>NX%7;MGM1IGTZ@/?33F73:
M=:%KNU?>\5'@')^KELV_:X5F[7)JUHX&5JTA=>R>:+:ML!N=$C.JS\QV8VI%
MYJ+-%QA+&7;MF%B#C_WN\?FD:=<G9ML4S('7AS&F'?%+U*V=SSIV8]H9U,4.
MT2<G=CTSSX3IB=V8 >SD@L@^452J8DET52Q37\"&1@@6)$6C A%5W?=*^P+\
M:!K1%76OLD+4YZ3Q 8A<CXO=HY#V2JA8-M#M-*OZP91YV*<AEU0[HC],].D=
MHHNZ03U==+ B&2*65<?'.F&@AASB,(=*AD3ETO[1P<E9_0Z]*ZOK.V$^2QA(
MPG2-6.+BJIKF.@(X N7BJYJ!,/I02H-H%'+QF7_73SC#K$B@\C0%QMNKK/91
MC/]UT 4,:3Q.\J=<;E<77%APQO=PX;(CEHN9Y5/@\6<_8 G* 6)KQ?UAXZ_5
M!7.[\?[RJ]7>1S"_L;=\ O629#4P-O8Y4*#(,!?*M\NNP?3NJ;HL63XO!ZFL
M3-1R5J^GL7)#GE= ZA>B/Y_.;]D;%Z1TL\U"743!$/<9MXFJLEC6E%'V?A)X
M6;]*!.'_2WG5_;UT1(&IG*0"'12?BW[N],95+0:X$^IFU70<1329O8<_/1@E
MBT=5WCW'"],PZ VK+DPT2V"4C#HA6W;BQ G@A]TX#.DH9=7EA_=+U5;H;9PW
M6O;NQ%D61_D 8"UF@4O#Q2#Y>$7Q C5#*XNBR+'+8!HS;SGP O%RCG@E\]:4
MZ65#N+]8*)/[F^ZZ_6G=5G*Z)<L*"_Z51EDI;P<,P[GT0PFTUBI/+;@$:B(O
M'G.>^T/(?]Z/J.<%PUY50"3O9@G#KJ\G])73I9*ORS7"8=W"OT^R/*+9LAR@
MCY/J$BX?!"?8'U$0SJK_L8,(U)_%)J@51W3XGW<I6/D@HY+ +RJFP9R!I .A
MD3]."D;2H)]<PBP8BXB<+<^MAEVOH3/[P*Z?H;/ZX7FK83?@XX%50_6_#_\\
ML([KZ+!IFHVSLT;3VB"$Y+4(M0_._FQ8QW;3>H=JY<,R.,6*;&P\V/_^@ZC"
M^SM@;B@O/0F'36/YHV;+1,_H2"S#-X4;_)+NPG3I+G3!##?M2[%;ZTG-]JEL
MU3ISLPWF^KP^M^;=OG7\)3#MW/P'T_^+[/WY*>R*X94S&(7FX'S:M+N7S9JK
M0'O!&IC3CMT=F+8I61&X&. RF-S\#_69.>A,+XBG@67OZ9@PWP5S7W>P85 %
MRT1V#=_3&#/ Y-7Q7W>-_6]SSF"<@ED[>R'6V1(.!R'>JELV:M4_-ULV^GS>
M.CL_@&>[R26\#6(<$0DU6X@H;[RWJ'FT\1C9?]9O*J=KQ71P: /XB!B2O$G<
MLR7R<3V8W(-#L8\2-HJ3#+U9/C,*/AQ+,\2N>'"Z*&;>V^JO$*:?<T^R7OB7
MJ]$9#[[!$8S9Y\VP1V=X!K!B-OS-I*\UA[[GKF+6W*DU/U<N1$=WB:0(6-,5
M#<L2B&-=D$4L,HU*OD)TW1. WLQED<,2D GO\BV$G5Q^,ICZH\!\]@AUB_6"
ME$?],PM*?C/V!^-C?J$+5)(]JF--%1PP/HB*'4GS,2&,BI[C:)*G@(+\\\#\
M#&KP##6MP^8)S, [U+ .R]_#^3N3^]M@OJE/J9OE[%IHEB6;(IJB=,1<'JGT
M4#!$098BMT]!L21O-QZM;\S^:HCPUP<$C;*N2-\3$)2$LB(JWQ4+>ZA,+"OZ
M][5\"%C1*!N2L27 PLRJFOR4<.!]L:QEJ$H<37FPZFX ^C:#%+SQZQ6T\$LT
M7V/HQ@D8I/E.]UD&)N%A/!YFR>PP]E;M11[-YWL:&1LE\17O9TL-Q6)7SYR?
M@N9K*&#\S9O'Y@S@X[^D,S]5++$5@I<TL>9'EQV[<7M7;V[5&M#V4K)JIMR9
M-X3.@/]^&5BU2ZE[?"YT[ /);+?Z9LBW<@]6=_5T1?%ERF3L&+J(9<W5L",X
MH'@EQAPF4$'3-6Y<AG1"$W:O9KT_6KM=''Y+%[P6M)Y]X1X%(8/>P?_8+<)'
M+,+&ZB*DL,PT17.Q3V0)RZ*D8,.!-:GKNBQICN@Z N7;PP0,8$60?^XJ7/A\
M&\6ONV7X?<O0IM/&(F7 S77H;DT^>DV>KJY)12:,^<S#DN,*&"C"L$.IC#71
ME37*#,^1_-*^(F(B"T13E <7Y99:@7?\I9R+W^2&&8H3U,SZ+$&?QDF0>H'+
M^6V+E^QZ9+=>$MU#P\,XBH*49RXCKKM1(2C>;K,J^;T(V&B=H7HT"N,92UZO
MK(E]M.(3_B"#;B"&KY0_?P9:.W'RR]!:M1J1%9??WA4JC\F>VNW-;L(.TH'G
M)2Q-%_].  "RE3[ #VTCD0M'\QQ5<R2LR+K.<UCRE'41RX8N28:DN)(#-CQ!
MY\,@?XTKFZ'/(9W3V[;\N^?<&[^/8N+O1S'Q NA$%<\@6/<EH)/B@=?%-!D[
MDN!*G@Y^%@6*G8T#<$ D07LY0AW"QV9BQY/MC#K_$)EF%[[J$L_SP3G6- ?(
MI'O8D#4#:PJCND8D061 IC^I>\F&*?Q].3KEOFHS^9S$5T'^ZMUKW$/X(6I*
M%X:JBYKNBUBCS,.RZ[N8JJZ$7=U019]HDB0#-;GN^P12DLUN4_.7$?-S#-0*
MN\&HV [ZW2@E7Z@ZT52-RMC0?!G+FJ!BG7I +D'U/5&65**ZI7U!4P6R=4D0
M;Q9$YJD%GQ-8K,&(AJ@^9>XX _6,FCZ8IRQ]5#[!MEBA+POGUSRC?_^ABT1[
MGZ*,A6S4CX<,#?. T#L$A C'W)-!-&$4UK;'JFB)VTL8SV^>4=IPK7X :/Y^
M\D5HVKT+5_,$09$TT..*BV5"-$P5@6(BJB[C)PLPA9;VQ;O"Y>USJH"3&)SD
MSYPIMW@WXX<$_^3"EU6J$MV%)>43_O*MB@W7<X R5!%]438,'P2_+NA8A[6^
MR:F?6^VX6Y6##8+Q'CUZ!!8N2Y"5I^DE:/&XU*Z!CP[[=-AC'CKC%C$ZH6F&
M6GD:^$ZW_C0X#_O,O419GR$Z N]BE 1\S\R)I\AA83SA9."%G#A(QW\A/PBY
MC@V 0/S #0_(D\4H#:)QF-$AB\=I.$,IS8+4G^4M%PUB!Y M@G9QT>6-M,PQ
M]),@.IPMR_PXA,%Y.^[Q!'S[)ZUN_F1N=H:F0DA9$8J!UZ=HKKS1NE*HY:^U
M/Y"#^+V%4EGX[K8/%<JZ_'B0U[\+390'7H9^PGO #T380^;?(=Q3X^MMZ)OW
MG_Y89/T9#:-V$F0@*_A6[GBX"-VG=R,<3AR'#H6%GX'XV4KCJ4@%Z=@N,6MU
MZ/-TUK3/9>NX(YIV;](='(@6P->L?0HZ\\X$8+^5"C+J6_/SB6E;8;?64"R[
M)W0'G6FS]C$R:QT8'_",/@VLP8'<#=<<=R.IBJ13@6$7O&PL*ZZ(J2\)6)6)
MH#)%<)AO<"%E:++\_N<F9_T,1OZI&T4+G@,T;C(=&HV3=,Q5#BBMUAB$KRPJ
M"_7#]<X9./'0,  X#MP,O2$:.CQJ(5$2RE#Q-6XU[7323B?]CCKI+ X#%U;Z
ML&>"P0M6;_B:%=*I",ICTHFLJ'O,VUS..G8XZ(@-H=G^%%H#?IR6.[?$-0JI
MU@%X/@8=L7O)(P!-^U._V;8&G<&ITHG.17-P%%AS4UJKD!17TSU=TS&0UP6%
MQ ^#]//XO>12S7-=C['?12%]93@4+3CNKC8B,@]BW5!(]:F;.\&KZD@6RD7-
MG4;:::2=1GH=&NESPKB'Q$_^R\]SX<&5I.G[/)#\:C73H!N9]I>!V0;8VJ<
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M,C$S+GAS9%!+ 0(4 Q0    ( "N C57+!USA@0D  $!6   5
M  "  1,7  !C<V)R+3(P,C(Q,C$S7VQA8BYX;6Q02P$"% ,4    "  K@(U5
M/9UG@$,&   ,+0  %0              @ ''(   8W-B<BTR,#(R,3(Q,U]P
M<F4N>&UL4$L! A0#%     @ *X"-50KN2%8!)   8GH" !T
M ( !/2<  &-S8G(X+6LQ,#,Q,C R,F5X.3DQ>'$R,C,N:'1M4$L%!@     %
-  4 3P$  'E+      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
